Epic Bio

Epic Bio is a leading epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company’s proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein known to work in human cells, enabling in vivo or ex vivo delivery via a single viral vector. Epic's lead program, EPI-321, is designed for the treatment of facioscapulohumeral muscular dystrophy (FSHD). 

Learn more at epicrispr.com